D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
PUT
Planet Fitness
PLNT
$4.43B
| $2.9M | ﹤0.01% |
38,900
| – | – |
|
|
JOYY
2127
CALL
JOYY Inc
JOYY
$3.68B
| $2.9M | ﹤0.01% |
54,900
| – | – |
|
2128
Sasol
SSL
$7.51B
| $2.9M | ﹤0.01% |
134,003
+9,947
| +8% | +$190K |
|
2129
PUT
Corteva
CTVA
$59.8B
| $2.89M | ﹤0.01% |
97,878
| – | – |
|
2130
Prologis
PLD
$136B
| $2.89M | ﹤0.01% |
32,443
-20,168
| -38% | -$1.79M |
|
2131
Cytokinetics
CYTK
$10.9B
| $2.89M | ﹤0.01% |
272,550
+232,113
| +574% | +$2.38M |
|
2132
CALL
Air Products & Chemicals
APD
$66.8B
| $2.89M | ﹤0.01% |
12,300
-6,400
| -34% | -$1.44M |
|
2133
Entravision Communication
EVC
$1.07B
| $2.88M | ﹤0.01% |
1,099,787
+65,535
| +6% | +$179K |
|
2134
PUT
W.P. Carey
WPC
$16.9B
| $2.88M | ﹤0.01% |
36,756
+10,210
| +38% | +$855K |
|
2135
First Bancorp
FBNC
$2.61B
| $2.87M | ﹤0.01% |
72,028
-1,494
| -2% | -$57.2K |
|
2136
PUT
EPAM Systems
EPAM
$5.42B
| $2.86M | ﹤0.01% |
13,500
-1,000
| -7% | -$197K |
|
|
AYX
2137
CALL
DELISTED
Alteryx Inc
AYX
| $2.86M | ﹤0.01% |
28,600
-20,000
| -41% | -$2.03M |
|
|
ESPR
2138
DELISTED
Esperion Therapeutics
ESPR
| $2.86M | ﹤0.01% |
47,975
+17,885
| +59% | +$804K |
|
|
THCBU
2139
DELISTED
Tuscan Holdings Corp. Unit
THCBU
| $2.86M | ﹤0.01% |
272,120
| – | – |
|
|
K
2140
PUT
DELISTED
Kellanova
K
| $2.85M | ﹤0.01% |
43,878
| – | – |
|
2141
Church & Dwight Co
CHD
$23.1B
| $2.85M | ﹤0.01% |
40,463
-1,547
| -4% | -$110K |
|
|
CAI
2142
DELISTED
CAI International, Inc.
CAI
| $2.84M | ﹤0.01% |
98,120
-15,262
| -13% | -$370K |
|
2143
PUT
Papa John's
PZZA
$995M
| $2.83M | ﹤0.01% |
44,800
| – | – |
|
2144
Center Bancorp
CNOB
$1.66B
| $2.83M | ﹤0.01% |
109,874
-1,138
| -1% | -$27.7K |
|
2145
PUT
IPG Photonics
IPGP
$3.6B
| $2.83M | ﹤0.01% |
19,500
-29,200
| -60% | -$4.06M |
|
|
AKCA
2146
DELISTED
Akcea Therapeutics Inc
AKCA
| $2.83M | ﹤0.01% |
166,789
+109,992
| +194% | +$2.05M |
|
2147
PUT
Fluor
FLR
$6.99B
| $2.82M | ﹤0.01% |
149,500
+29,200
| +24% | +$531K |
|
|
REVG
2148
DELISTED
REV Group
REVG
| $2.82M | ﹤0.01% |
230,635
+192,949
| +512% | +$2.44M |
|
2149
Fresenius Medical Care
FMS
$13.8B
| $2.81M | ﹤0.01% |
76,405
+68,731
| +896% | +$2.44M |
|
2150
CALL
Acuity Brands
AYI
$10.1B
| $2.8M | ﹤0.01% |
20,300
-21,100
| -51% | -$2.71M |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.